Search results
20 lut 2018 · Fact sheet on salmonella providing key facts and information on sources and transmission, prevention, treatment, recommendations to travellers, food handlers, food producers and WHO response.
In 2021, WHO has organized a stakeholder consultation to discuss the product development strategy for broadly protective salmonella vaccines, as a first step to develop an iNTS vaccine development roadmap and WHO Preferred Product Characteristics (PPCs).
30 mar 2023 · In addition to decreasing the disease burden in endemic countries and saving lives, widespread use of the typhoid conjugate vaccine in affected countries is expected to reduce the need for antibiotics for typhoid treatment and slow the increase in antibiotic resistance in Salmonella Typhi.
A VACCINE TO PREVENT INVASIVE SALMONELLADISEASE INCLUDING NTS AND TYPHOID FEVER IN SUB-SAHARAN AFRICA • Need a single combination vaccine to cover main NTS serovars: S. Typhimurium and variants (I:4,[5],12:i), S. Enteritidis& S. Dublin) • Vaccine must be compatible with the Expanded Programmeon Immunization (EPI) schedule for sub-Saharan Africa
With other new vaccines under investigation, including live-attenuated, protein-based and GMMA vaccines, now is an exciting time for the Salmonella vaccine field. Keywords: vaccines, Salmonella, nontyphoidal, typhoid, enteric, global health, glycoconjugate, GMMA. Protection Against more than Diarrhea
The potential public health value of vaccines against nontyphoidal salmonella (NTS) infections is becoming an increasingly important question, with several candidate vaccines now in development against invasive NTS disease (iNTS).
2 cze 2023 · Typhoid conjugate vaccines are efficacious against Salmonella Typhi. Globally, most Salmonella disease in humans is caused by non-Typhi Salmonella serovars. Nontyphoidal Salmonella and paratyphoid require combination Salmonella vaccines. A quadrivalent Salmonella vaccine could prevent a large majority of Salmonella disease.
